Literature DB >> 31317459

Laparoscopic Versus Open Surgery for Gastric Gastrointestinal Stromal Tumors: a Propensity Score Matching Analysis.

Zhen Xiong1, Wenze Wan1, Xiangyu Zeng1, Weizhen Liu1, Tao Wang1, Ruizhi Zhang1, Chengguo Li1, Wenchang Yang1, Peng Zhang2, Kaixiong Tao3.   

Abstract

BACKGROUND: Surgery is the first choice for the treatment of gastric gastrointestinal stromal tumors (GISTs). With the development of new instruments and techniques, the popularity of laparoscopic resection of GISTs has increased rapidly. Previous studies on the advantages of laparoscopic resection over open surgery are generally limited by methodology or data capacity. This study evaluated the efficacy of laparoscopic resection and open surgery in gastric GISTs using the propensity score matching (PSM) method.
METHODS: Between January 2005 and December 2017, 1027 patients were diagnosed with primary GIST at our institution. Among them, 548 patients were enrolled in this study. Standard demographic and clinicopathological data were collected from our database. Selection bias was eliminated using the PSM methods.
RESULTS: After PSM, 256 cases involved in the comparison (128 laparoscopic (LAP) vs. 128 open surgery (OPEN)) were randomly matched (1:1) by age, sex, body mass index, hypertension, diabetes, heart disease, year of surgery, tumor location, tumor size, mitotic rate, and treatment with adjuvant tyrosine kinase inhibitors. The LAP group was superior to the OPEN group in blood loss (χ2 = 6.048, P = 0.049), time to first flatus (49.41 ± 7.56 vs. 71.31 ± 4.87 h, P < 0.001), and hospital stay (10.21 ± 6.05 vs. 12.56 ± 5.43 days, P = 0.001). No significant differences were seen in either the relapse-free survival or overall survival between the LAP and OPEN groups. In tumors located in favorable locations, the LAP group showed less blood loss (P = 0.008) and less multivisceral resection (17.8% vs. 5.5%, P = 0.02).
CONCLUSIONS: Laparoscopic resection for gastric GISTs is associated with improved surgical outcomes and postoperative courses and comparable oncological outcomes, regardless of favorable or unfavorable tumor location.

Entities:  

Keywords:  GISTs; Laparoscopic surgery; Open surgery; Propensity score matching

Mesh:

Year:  2019        PMID: 31317459     DOI: 10.1007/s11605-019-04318-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  3 in total

1.  Surgical treatment of gastrointestinal stromal tumour of jejunum.

Authors:  G Panagiotakis; K Spiridakis; M Chatziioannou; N Kontopodis; S Kandylakis
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

2.  NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors.

Authors:  George D Demetri; Margaret von Mehren; Cristina R Antonescu; Ronald P DeMatteo; Kristen N Ganjoo; Robert G Maki; Peter W T Pisters; Chandrajit P Raut; Richard F Riedel; Scott Schuetze; Hema M Sundar; Jonathan C Trent; Jeffrey D Wayne
Journal:  J Natl Compr Canc Netw       Date:  2010-04       Impact factor: 11.908

3.  Laparoscopic versus open resection for gastric gastrointestinal stromal tumors: a meta-analysis.

Authors:  Lijun Zheng; Weixing Ding; Donglei Zhou; Liesheng Lu; Le Yao
Journal:  Am Surg       Date:  2014-01       Impact factor: 0.688

  3 in total
  2 in total

1.  Laparoscopic vs. open surgery for gastrointestinal stromal tumors of esophagogastric junction: A multicenter, retrospective cohort analysis with propensity score weighting.

Authors:  Wenjun Xiong; Yuting Xu; Tao Chen; Xingyu Feng; Rui Zhou; Jin Wan; Yong Li; Guoxin Li; Wei Wang
Journal:  Chin J Cancer Res       Date:  2021-02-28       Impact factor: 5.087

2.  Early experience of laparoscopic resection and comparison with open surgery for gastric gastrointestinal stromal tumor: a multicenter retrospective study.

Authors:  Shin-Hoo Park; Hyuk-Joon Lee; Min-Chan Kim; Jeong-Hwan Yook; Tae-Sung Sohn; Woo-Jin Hyung; Seung-Wan Ryu; Yukinori Kurokawa; Young-Woo Kim; Sang-Uk Han; Hyung-Ho Kim; Do-Joong Park; Wook Kim; Sang-Il Lee; Haruhiko Cho; Gyu-Seok Cho; Jin-Jo Kim; Ki-Han Kim; Moon-Won Yoo; Han-Kwang Yang
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.